Kardiovaskuläre Risiken der Androgendeprivationstherapie beim Prostatakarzinom
Crossref DOI link: https://doi.org/10.1007/s00120-015-0021-1
Published Online: 2016-03-22
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miller, K.
Text and Data Mining valid from 2016-03-22